Clinical Trial Update: Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia [Phase 4]

View source ↗

Summary

A Phase 4 trial at Albert Einstein College of Medicine assessed whether combining exenatide and pramlintide can reduce post-prandial hyperglycemia in people wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• pramlintide (pramlintide)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2018-02-08